DC Chemicals

All products / DC47763

Vevorisertib trihydrochloride
CAT. NO. DC47763

Vevorisertib trihydrochloride

Pack sizes and prices

Pack sizePrice
100 mg$800 USDRequest a quote / confirm availability →
250 mg$1,450 USDRequest a quote / confirm availability →
1 g$2,900 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

Vevorisertib (ARQ 751) (trihydrochloride) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor against AKT1 (IC50=0.55 nM), AKT2 (IC50=0.81 nM), and AKT3 (IC50=1.31 nM). Vevorisertib (trihydrochloride), as a single agent or in combination with other anti-cancer agents, can be used for the research of solid tumors with PIK3CA / AKT / PTEN mutations.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC47763
Product nameVevorisertib trihydrochloride
CAS1416775-08-0
Molecular formulaC35H41Cl3N8O
Molecular weight696.1
Purity>98%
SMILESCC(=O)N(C)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1.Cl.Cl.Cl

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Vevorisertib trihydrochloride (DC47763)

Related research products

Browse newly added products